胃潰瘍(Gastric Ulcers):世界の治験レビュー(2015年上半期版)

【英語タイトル】Gastric Ulcers Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2677CTIDB)・商品コード:GDHC2677CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年4月30日
・ページ数:91
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における胃潰瘍(Gastric Ulcers) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 胃潰瘍(Gastric Ulcers)
  - 当レポートの概要
・胃潰瘍(Gastric Ulcers):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Gastric Ulcers Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Gastric Ulcers Global Clinical Trials Review, H1, 2015″ provides data on the Gastric Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastric Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastric Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Gastric Ulcers 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gastric Ulcers to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gastric Ulcers to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Gastric Ulcers 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Gastric Ulcers Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Takeda Pharmaceutical Company Limited 36
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36
Pozen, Inc. 38
Clinical Trial Overview of Pozen, Inc. 38
Eisai Co., Ltd. 39
Clinical Trial Overview of Eisai Co., Ltd. 39
Dr. Reddy’s Laboratories Limited 40
Clinical Trial Overview of Dr. Reddy’s Laboratories Limited 40
Bluefish Pharmaceuticals AB 41
Clinical Trial Overview of Bluefish Pharmaceuticals AB 41
Emcure Pharmaceuticals Ltd. 42
Clinical Trial Overview of Emcure Pharmaceuticals Ltd. 42
Chemo Espana, S.A. 43
Clinical Trial Overview of Chemo Espana, S.A. 43
Aspen Pharmacare Holdings Ltd 44
Clinical Trial Overview of Aspen Pharmacare Holdings Ltd 44
Alvogen, Inc. 45
Clinical Trial Overview of Alvogen, Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
Medical Co. LTA Clinical Pharmacology Center 46
Clinical Trial Overview of Medical Co. LTA Clinical Pharmacology Center 46
Chinese University of Hong Kong 47
Clinical Trial Overview of Chinese University of Hong Kong 47
Hamamatsu University 48
Clinical Trial Overview of Hamamatsu University 48
Keio University 49
Clinical Trial Overview of Keio University 49
The Catholic University of Korea 50
Clinical Trial Overview of The Catholic University of Korea 50
The University of Tokyo Hospital 51
Clinical Trial Overview of The University of Tokyo Hospital 51
Tsuchiura Kyodo General Hospital 52
Clinical Trial Overview of Tsuchiura Kyodo General Hospital 52
University of Missouri 53
Clinical Trial Overview of University of Missouri 53
Yokohama City University 54
Clinical Trial Overview of Yokohama City University 54
Brigham and Women’s Hospital 55
Clinical Trial Overview of Brigham and Women’s Hospital 55
Five Key Clinical Profiles 56
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
About GlobalData 91
Contact Us 91
Disclaimer 91
Source 91

List of Tables
Gastric Ulcers Therapeutics, Global, Clinical Trials by Region, 2015* 7
Gastric Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastric Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastric Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Gastric Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Gastric Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Gastric Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Gastric Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Gastric Ulcers to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Gastric Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Gastric Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Gastric Ulcers to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Gastric Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Gastric Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Gastric Ulcers Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Gastric Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Gastric Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Gastric Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Gastric Ulcers Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Gastric Ulcers Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Gastric Ulcers Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Gastric Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Gastric Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Gastric Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Gastric Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Gastric Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 34
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 36
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Pozen, Inc., 2015* 38
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 39
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 40
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2015* 41
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Emcure Pharmaceuticals Ltd., 2015* 42
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015* 43
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Aspen Pharmacare Holdings Ltd, 2015* 44
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Alvogen, Inc., 2015* 45
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Co. LTA Clinical Pharmacology Center, 2015* 46
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 47
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University, 2015* 48
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015* 49
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by The Catholic University of Korea, 2015* 50
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2015* 51
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Tsuchiura Kyodo General Hospital, 2015* 52
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2015* 53
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 54
Gastric Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015* 55

List of Figures
Gastric Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Gastric Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastric Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastric Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Gastric Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Gastric Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Gastric Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Gastric Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Gastric Ulcers to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Gastric Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Gastric Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Gastric Ulcers to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Gastric Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Gastric Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Gastric Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Gastric Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Gastric Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Gastric Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Gastric Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Gastric Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Gastric Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Gastric Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Gastric Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 90

【掲載企業】

AstraZeneca PLC
Takeda Pharmaceutical Company Limited
Pozen, Inc.
Eisai Co., Ltd
Dr. Reddy's Laboratories Limited
Bluefish Pharmaceuticals AB
Emcure Pharmaceuticals Ltd
Chemo Espana, S.A.
Aspen Pharmacare Holdings Ltd
Alvogen, Inc.

【レポートのキーワード】

胃潰瘍(Gastric Ulcers)、治験、臨床試験、治験、治療薬

★調査レポート[胃潰瘍(Gastric Ulcers):世界の治験レビュー(2015年上半期版)] (コード:GDHC2677CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[胃潰瘍(Gastric Ulcers):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆